Patients entered into MRC AML trials are biologically representative of the totality of the disease in the UK

A. V. Moorman, E. Roman, R. A. Cartwright, G. J. Morgan

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)263-265
Number of pages3
JournalClinical and Laboratory Haematology
Issue number4
StatePublished - Sep 18 2002
Externally publishedYes

ASJC Scopus subject areas

  • Hematology

Cite this